Concepedia

Exploring the “iron shuttle” hypothesis in chelation therapy: Effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture

Gabriela Link, Abraham M. Konijn, William Breuer, Z. Ioav Cabantchik, Chaim Hershko

Journal of Laboratory and Clinical Medicine · 2001 · 112 citations · 30 references

DOI

Concepts

References

30

Survival in Medically Treated Patients with Homozygous β-Thalassemia

Nancy F. Olivieri, David G. Nathan, James H. MacMillan et al. · New England Journal of Medicine · 1994 · 864 citations · Full text

, , +15

Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major

Gary M. Brittenham, Christine E. McLaren, Douglas M. Templeton et al. · New England Journal of Medicine · 1998 · 420 citations · Full text

, , +17

Iron-Chelation Therapy with Oral Deferiprone in Patients with Thalassemia Major

Nancy F. Olivieri, Gary M. Brittenham, Doreen Matsui et al. · New England Journal of Medicine · 1995 · 327 citations

, , +15

Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk β-thalassemia

Bernard A. Davis, John B. Porter · Blood · 2000 · 280 citations

, , +11

A simple technique for measuring storage iron concentrations in formalinised liver samples.

J. D. Torrance, T. H. Bothwell · PubMed · 1968 · 267 citations

, , +11